NDC Code(s) : 69844-036-01, 69844-036-02, 69844-036-03, 69844-036-04
Packager : Graviti Pharmaceuticals Private Limited
Category : HUMAN PRESCRIPTION DRUG LABEL
DEA Schedule : none
Marketing Status : New Drug Application
INGREDIENTS AND APPEARANCE
CLOPIDOGREL BISULFATE CLOPIDOGREL BISULFATE TABLET | ||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
LABELER - Graviti Pharmaceuticals Private Limited(650884781) |
REGISTRANT - Graviti Pharmaceuticals Private Limited(650884781) |
Establishment | |||
Name | Address | ID/FEI | Business Operations |
Graviti Pharmaceuticals Private Limited | 650884781 | manufacture(69844-036), analysis(69844-036) |
PRINCIPAL DISPLAY PANEL
NDC 69844- 036-01
Clopidogrel Tablets, USP
75 mg
PHARMACIST: Dispense the Medication Guide provided separately to each patient.
Rx Only
30 Tablets
Graviti Pharma